NeoModulus (Suzhou) Medical Technology Co., Ltd.
China
Nuo Yi Mai Er (Suzhou) Medical Technology Co., Ltd. was established in March 2017, headquartered in Suzhou High-tech Zone. It is an innovative high-tech enterprise co-founded by a Sino-German scientist team led by a national major talent program awardee, and is also a Suzhou Unicorn Cultivation Enterprise. The company is rooted in the fields of tissue engineering and regenerative medicine, committed to 'achieving human tissue repair and organ regeneration', and focuses on the R&D, production, and commercialization of regenerative implantable medical devices. Leveraging its self-developed, globally leading 3D electrospinning and 3D bioprinting equipment and technologies, and using natural and synthetic polymer materials, the company develops a variety of implantable devices including sponges, gels, scaffolds, membranes, and microspheres, covering clinical fields such as head, neck, and oral, sports medicine, nerve repair, reproductive medicine, and ophthalmology. Its innovative product, the nasal hemostatic sponge (Neosprout), has obtained domestic registration certificates as well as CE MDR and FDA international certifications. The company operates two domestic R&D and production bases and an overseas laboratory in Freiburg, Germany. To date, it has applied for over 160 patents and has 20 Class III implantable medical devices under development. The company is dedicated to overcoming the challenges of tissue repair and organ regeneration through comprehensive innovation in materials, processes, and equipment, and to building a comprehensive service platform for bionic organ manufacturing.
